In this issue:
Intravenous iron therapy for patients with HF and iron deficiency
Digitoxin in patients with HFrEF<br>
Mavacamten in symptomatic nonobstructive hypertrophic cardiomyopathy
Clopidogrel vs aspirin for secondary prevention of CAD
Influence of type 2 diabetes on the effects of tirzepatide in patients with HFpEF and obesity
Semaglutide and tirzepatide in patients with HFpEF
Beta-blockers after MI without reduced ejection fraction
Beta-blockers after MI in patients without HF
Herpes zoster vaccine effectiveness against cardiovascular events
Glucose-lowering drug classes and cardiovascular outcomes in type 2 diabetes
Please login below to download this issue (PDF)